Nicholas Hollmeyer Lynton - 23 Jun 2025 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Jun 2025, 16:11:45 UTC
Prior SEC filing
22 Apr 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nick Lynton

Key filing fact

Nicholas Hollmeyer Lynton filed Form 4 for Cardlytics, Inc. (CDLX) on 25 Jun 2025.

Key facts

  • This page summarizes Nicholas Hollmeyer Lynton's Form 4 filing for Cardlytics, Inc. (CDLX).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 Jun 2025, 16:11.

Change

  • Previous filing in this sequence was filed on 22 Apr 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001941467 Primary reporting owner

Lynton Nicholas Hollmeyer

Relationship
Chief Legal & Privacy Officer
Address
675 PONCE DE LEON AVENUE NE, SUITE 4100, ATLANTA
Signature
/s/ Nick Lynton
Signature date
25 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDLX transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+25,000
Change %
Price
$0.000000
Shares after
25,000
Date
23 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,000
Exercise price
Footnotes
F1, F2
CDLX transaction Derivative

Performance Stock Unit

Award

Transaction value
$0
Shares
+9,375
Change %
Price
$0.000000
Shares after
9,375
Date
23 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,375
Exercise price
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

50% of the shares underlying the RSU award will vest on June 23, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through June 23, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Footnote F3

Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F4

The PSU vests in specified percentages upon achievement of specified price per share targets, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .